Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of the Reflux Disease Questionnaire in primary care patients treated with esomeprazole
2004-005169-39Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Primary endpoint: Accuracy of RDQ for GERD diagnosis. Started Jun 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2004-005169-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005169-39.